In the late stages of PD, the key molecular pathogenic mechanisms include the misfolding and aggregation of -synuclein, mitochondrial dysfunction, impaired protein clearance (related to inefficient ubiquitin-proteasome and autophagy-lysosomal systems), neuroinflammation and oxidative stress (57)
Eli Lilly oral tirzepatide development Eli Lilly, the company behind Mounjaro and Zepbound, is actively developing oral tirzepatide formulations using proprietary technology that addresses the bioavailability challenges that compounded drops cannot solve
Differentiated cells can only express genes that characterize a certain type of cell, such as a liver cell, for example
Based on the structures of co-crystallized ligands and modeled UDP-glucose into the UGT74F2, we propose that SGE is formed by S N 2 attack from the SA carboxylate group
Cell Host Microbe 31, 712733